These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25328151)

  • 1. Genetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtype.
    Taylor NJ; Bensen JT; Poole C; Troester MA; Gammon MD; Luo J; Millikan RC; Olshan AF
    Mol Carcinog; 2015 Dec; 54(12):1668-77. PubMed ID: 25328151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Breast Cancer Res Treat; 2011 Sep; 129(2):593-606. PubMed ID: 21516303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer.
    Mesic A; Rogar M; Hudler P; Juvan R; Komel R
    IUBMB Life; 2016 Aug; 68(8):634-44. PubMed ID: 27270838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.
    Bensen JT; Tse CK; Nyante SJ; Barnholtz-Sloan JS; Cole SR; Millikan RC
    Cancer Causes Control; 2013 Jun; 24(6):1099-109. PubMed ID: 23526039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
    Blanco I; Kuchenbaecker K; Cuadras D; Wang X; Barrowdale D; de Garibay GR; Librado P; Sánchez-Gracia A; Rozas J; Bonifaci N; McGuffog L; Pankratz VS; Islam A; Mateo F; Berenguer A; Petit A; Català I; Brunet J; Feliubadaló L; Tornero E; Benítez J; Osorio A; Ramón y Cajal T; Nevanlinna H; Aittomäki K; Arun BK; Toland AE; Karlan BY; Walsh C; Lester J; Greene MH; Mai PL; Nussbaum RL; Andrulis IL; Domchek SM; Nathanson KL; Rebbeck TR; Barkardottir RB; Jakubowska A; Lubinski J; Durda K; Jaworska-Bieniek K; Claes K; Van Maerken T; Díez O; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; de la Hoya M; Caldés T; Dunning AM; Oliver C; Fineberg E; Cook M; Peock S; McCann E; Murray A; Jacobs C; Pichert G; Lalloo F; Chu C; Dorkins H; Paterson J; Ong KR; Teixeira MR; ; Hogervorst FB; van der Hout AH; Seynaeve C; van der Luijt RB; Ligtenberg MJ; Devilee P; Wijnen JT; Rookus MA; Meijers-Heijboer HE; Blok MJ; van den Ouweland AM; Aalfs CM; Rodriguez GC; Phillips KA; Piedmonte M; Nerenstone SR; Bae-Jump VL; O'Malley DM; Ratner ES; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Bojesen A; Pedersen IS; Sunde L; Jensen UB; Thomassen M; Kruse TA; Foretova L; Peterlongo P; Bernard L; Peissel B; Scuvera G; Manoukian S; Radice P; Ottini L; Montagna M; Agata S; Maugard C; Simard J; Soucy P; Berger A; Fink-Retter A; Singer CF; Rappaport C; Geschwantler-Kaulich D; Tea MK; Pfeiler G; ; John EM; Miron A; Neuhausen SL; Terry MB; Chung WK; Daly MB; Goldgar DE; Janavicius R; Dorfling CM; van Rensburg EJ; Fostira F; Konstantopoulou I; Garber J; Godwin AK; Olah E; Narod SA; Rennert G; Paluch SS; Laitman Y; Friedman E; ; Liljegren A; Rantala J; Stenmark-Askmalm M; Loman N; Imyanitov EN; Hamann U; ; Spurdle AB; Healey S; Weitzel JN; Herzog J; Margileth D; Gorrini C; Esteller M; Gómez A; Sayols S; Vidal E; Heyn H; ; Stoppa-Lyonnet D; Léoné M; Barjhoux L; Fassy-Colcombet M; de Pauw A; Lasset C; Ferrer SF; Castera L; Berthet P; Cornelis F; Bignon YJ; Damiola F; Mazoyer S; Sinilnikova OM; Maxwell CA; Vijai J; Robson M; Kauff N; Corines MJ; Villano D; Cunningham J; Lee A; Lindor N; Lázaro C; Easton DF; Offit K; Chenevix-Trench G; Couch FJ; Antoniou AC; Pujana MA
    PLoS One; 2015; 10(4):e0120020. PubMed ID: 25830658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
    BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 with the risk of endometrial carcinoma and clinicopathological parameters among Chinese Han women.
    Zheng LY; Song AP; Chen L; Liu DG; Li XH; Guo HY; Tian XX; Fang WG
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():65-72. PubMed ID: 25463638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Risk Associated with Genotype Polymorphisms of the Aurora Kinase a Gene (AURKA): a Case-Control Study in a High Altitude Ecuadorian Mestizo Population.
    López-Cortés A; Cabrera-Andrade A; Oña-Cisneros F; Echeverría C; Rosales F; Ortiz M; Tejera E; Paz-Y-Miño C
    Pathol Oncol Res; 2018 Jul; 24(3):457-465. PubMed ID: 28647900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features.
    Ingebriktsen LM; Humlevik ROC; Svanøe AA; Sæle AKM; Winge I; Toska K; Kalvenes MB; Davidsen B; Heie A; Knutsvik G; Askeland C; Stefansson IM; Hoivik EA; Akslen LA; Wik E
    Breast Cancer Res; 2024 Aug; 26(1):126. PubMed ID: 39198859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive effects of
    Huang C; Wang L; Song H; Wu C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2333-2337. PubMed ID: 31174434
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.
    Family L; Bensen JT; Troester MA; Wu MC; Anders CK; Olshan AF
    Breast Cancer Res Treat; 2015 Jan; 149(1):181-90. PubMed ID: 25417172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of associations between
    Tang J; Qian Y; Zhu J; Zhang J; Wang FH; Zeng JH; Liang JH; Wang H; Xia H; He J; Liu W
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29678897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
    Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
    PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AURKA gene rs2273535 polymorphism contributes to breast carcinoma risk - meta-analysis of eleven studies.
    Guo XG; Zheng L; Feng WB; Xia Y
    Asian Pac J Cancer Prev; 2014; 15(16):6709-14. PubMed ID: 25169513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population.
    Ruan Y; Song AP; Wang H; Xie YT; Han JY; Sajdik C; Tian XX; Fang WG
    J Pathol; 2011 Dec; 225(4):535-43. PubMed ID: 21598251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women.
    Zheng L; Song A; Ruan Y; Chen L; Liu D; Li X; Guo H; Han J; Li Y; Tian X; Fang W
    Cancer Epidemiol; 2013 Oct; 37(5):639-46. PubMed ID: 23787073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
    Yang PJ; Hsieh MJ; Lee CI; Yen CH; Wang HL; Chiang WL; Liu TC; Tsao TC; Lee CY; Yang SF
    Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33050100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects.
    Sun H; Bai J; Chen F; Jin Y; Yu Y; Fu S
    Breast Cancer Res Treat; 2011 Jan; 125(1):175-9. PubMed ID: 20464476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.